J Korean Med Assoc.  2010 Mar;53(3):245-249. 10.5124/jkma.2010.53.3.245.

Revised FIGO Staging System

• Ryu HS

• KMID: 1775336
• DOI: http://doi.org/10.5124/jkma.2010.53.3.245

Abstract

The International Federation of Gynecology and Obstetrics (FIGO) updated the staging system for carcinoma of the vulva, cervix, and endometrium in 2009. A new staging system for uterine sarcoma has been designed. This review summarizes the changes. There were minor changes in carcinoma of endometrium and cervix. The staging systems for uterine sarcomas were newly developed. Major changes were made for the carcinoma of vulva. There were no changes for cancer of the ovary, tube, vagina, and gestational trophoblastic neoplasia.

Keyword

FIGO staging; Gynecologic cancer

MeSH Terms

Cervix Uteri
Endometrial Neoplasms
Endometrium
Female
Gestational Trophoblastic Disease
Gynecology
Obstetrics
Ovarian Neoplasms
Sarcoma
Vagina
Vulva

Reference

1. Pecorelli S. Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. Int J Gynaecol Obstet. 2009. 105:103–104.

2. Creasman W. Revised FIGO staging for carcinoma of the endometrium. Int J Gynaecol Obstet. 2009. 105:109.

3. Pecorelli S, Zigliani L, Odicino F. Revised FIGO staging for carcinoma of the cervix. Int J Gynaecol Obstet. 2009. 105:107–108.

4. Burghardt E, Ostor A, Fox H. The new FIGO definition of cervical cancer stage IA: a critique. Gynecol Oncol. 1997. 65:1–5.

5. Cheng X, Cai S, Li Z, Tang M, Xue M, Zang R. The prognosis of women with stage IB1-IIB node-positive cervical carcinoma after radical surgery. World J Surg Oncol. 2004. 2:47.

6. Hricak H, Gatsonis C, Coakley FV, Snyder B, Reinhold C, Schwartz LH, Woodward PJ, Pannu HK, Amendola M, Mitchell DG. Early invasive cervical cancer: CT and MR imaging in preoperative evaluation-ACRIN/GOG comparative study of diagnostic performance and interobserver variability. Radiology. 2007. 245:491–498.

7. Hong JH, Tsai CS, Lai CH, Chang TC, Wang CC, Chou HH, Lee SP, Lee CC, Tang SG, Hsueh S. Risk stratification of patients with advanced squamous cell carcinoma of cervix treated by radiotherapy alone. Int J Radiat Oncol Biol Phys. 2005. 63:492–499.

8. Horn LC, Fischer U, Raptis G, Bilek K, Hentschel B. Tumor size is of prognostic value in surgically treated FIGO stage II cervical cancer. Gynecol Oncol. 2007. 107:310–315.

9. Homesley HD, Bundy BN, Sedlis A, Yordan E, Berek JS, Jahshan A, Mortel R. Assessment of current International Federation of Gynecology and Obstetrics staging of vulvar carcinoma relative to prognostic factors for survival (a Gynecologic Oncology Group study). Am J Obstet Gynecol. 1991. 164:997–1003. discussion 1003-1004.

10. Tantipalakorn C, Robertson G, Marsden DE, Gebski V, Hacker NF. Outcome and patterns of recurrence for International Federation of Gynecology and Obstetrics (FIGO) stages I and II squamous cell vulvar cancer. Obstet Gynecol. 2009. 113:895–901.

11. Hacker NF. Revised FIGO staging for carcinoma of the vulva. Int J Gynaecol Obstet. 2009. 105:105–106.

12. Fons G, Hyde SE, Buist MR, Schilthuis MS, Grant P, Burger MP, van der Velden J. Prognostic value of bilateral positive nodes in squamous cell cancer of the vulva. Int J Gynecol Cancer. 2009. 19:1276–1280.

13. Prat J. FIGO staging for uterine sarcomas. Int J Gynaecol Obstet. 2009. 104:177–178.